Predicting pharmacokinetics of anti-cancer drug, famitinib in human using physiologically based pharmacokinetic model / 药学学报
Acta Pharmaceutica Sinica
; (12): 1684-1688, 2014.
Article
em Zh
| WPRIM
| ID: wpr-251836
Biblioteca responsável:
WPRO
ABSTRACT
This study is to establish physiologically based pharmacokinetic (PBPK) models of famitinib in rat and monkey, and then to predict the pharmacokinetics and tissue distribution of famitinib in human based on the PBPK models. According to published paper, previous studies and the chemical properties of famitinib predicted by ACD/ADME suite and SimCYP, the PBPK models of rat and monkey were established and optimized using GastroPlus. And then, the PBPK models were applied to predict the pharmacokinetic and tissue distribution of famitinib in human. The results showed that the PBPK models of rat and monkey can fit the observed data well, and the AUC0-∞, ratios of observed and calculated data in rat and monkey were 1.00 and 0.97, respectively. The AUC0-∞, ratios of observed and predicted data in human were 1.63 (rat to human) and 1.57 (monkey to human), respectively. The rat and monkey PBPK models of famitinib were well established, and the PBPK models were applied in predicting pharmacokinetic of famitinib in human successfully. Hence, the PBPK model of famitinib in human could be applied in future drug-drug interaction study.
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Pirróis
/
Farmacocinética
/
Distribuição Tecidual
/
Haplorrinos
/
Receptores Proteína Tirosina Quinases
/
Indóis
/
Modelos Biológicos
/
Antineoplásicos
Tipo de estudo:
Prognostic_studies
Limite:
Animals
/
Humans
Idioma:
Zh
Revista:
Acta Pharmaceutica Sinica
Ano de publicação:
2014
Tipo de documento:
Article